Clinical Evaluation of Individualized Homoeopathic Medicines in Smokeless Tobacco Dependence: A Prospective, Single-Blind Interventional Cohort Study

Background: Smokeless tobacco (SLT) dependence is a pervasive public health burden across South Asia, driving high rates of oral potentially malignant disorders and cardiovascular morbidity. Conventional nicotine replacement and pharmacotherapeutic regimens show modest long-term abstinence rates in SLT chewers. Although classical homoeopathic literature describes several remedies for the constitutional and toxicological effects of tobacco, prospective clinical data evaluating individualized prescriptions remain sparse. Objectives: To evaluate the clinical effectiveness of individualized homoeopathic medicines in reducing physical nicotine dependence, subjective craving intensity, oral-health-related quality of life impairment, and daily chewing frequency among chronic smokeless tobacco users over a 6-month follow-up period. Methods: A prospective, single-blind, interventional clinical study was conducted on 100 adult smokeless tobacco users (aged 20–60 years; baseline FTND-ST score ≥ 4) at the outpatient department of Prayas Nasha-Mukti Evam Manochikitsa Kendra, Bhopal, India. Following detailed case-taking and repertorization using the Complete Repertory in CARA software, patients received one of eleven individualized homoeopathic remedies, with interspersed Sacchrum lactis (Rubrum) placebo phases to preserve single-blinding. Prescriptions distributed in descending order of clinical frequency were Arsenicum album (n = 16), Cinchona officinalis [China] (n = 14), Nux vomica (n = 13), Tabacum (n = 11), Ignatia amara (n = 10), Staphysagria (n = 9), Natrum carbonicum (n = 8), Caladium seguinum (n = 7), Erythroxylum coca (n = 5), Phosphorus (n = 4), and Spigelia anthelmia (n = 3). Outcomes were assessed at baseline and 6 months using the Fagerström Test for Nicotine Dependence–Smokeless Tobacco (FTND-ST), Oral Health Impact Profile (OHIP-18), Daily Tobacco Consumption Frequency (sessions/day), and a 0–10 Subjective Craving Visual Analogue Scale. Results: At the 6-month endpoint, statistically significant reductions were observed across the cohort (N = 100) in FTND-ST scores (6.01 ± 1.99 to 4.38 ± 2.68; mean reduction: 1.63 ± 2.07; Wilcoxon p < 0.001; d = 0.79, r = 0.45), OHIP-18 scores (baseline: 25.14 ± 8.77 vs. 6 months: 20.45 ± 9.99; mean reduction: 4.69 ± 4.17; t = 11.24, p < 0.001; Cohen’s d = 1.12), and subjective craving intensity (7.35 ± 1.84 to 5.89 ± 2.95; mean reduction: 1.46 ± 2.58; Wilcoxon p < 0.001; d = 0.57, r = 0.35). Daily chewing frequency declined from 15.10 ± 5.07 to 14.17 ± 7.09 sessions/day (mean difference: 0.93 ± 4.99; paired t-test p = 0.065; d = 0.19). Subgroup analysis demonstrated distinct clinical profiles: Ignatia amara (Δ = 6.00 ± 4.19, p = 0.001), China (Δ = 5.79 ± 4.58, p = 0.004), Staphysagria (Δ = 5.78 ± 4.66, p = 0.006), and Arsenicum album (Δ = 5.25 ± 3.04, p < 0.001) produced pronounced improvements in oral quality of life and dependence, whereas Tabacum (n = 11) achieved the most marked reduction in daily chewing sessions (Δ = 3.73 ± 4.38, p = 0.008, d = 0.85).

Authors

Institutions

Publication Details

Journal
International Journal of Drug Delivery Technology
Published
2026-11-14
DOI
https://doi.org/10.25258/ijddt.16.89s.183
Primary Topic
Complementary and Alternative Medicine Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical Evaluation of Individualized Homoeopathic Medicines in Smokeless Tobacco Dependence: A Prospective, Single-Blind Interventional Cohort Study

Jay Nilesh Shah, Lily Jain, Mahan Choudhary, Shipra Verma Ronia et al.
International Journal of Drug Delivery Technology
Complementary and Alternative Medicine Studies
article

Clinical Evaluation of Individualized Homoeopathic Medicines in Smokeless Tobacco Dependence: A Prospective, Single-Blind Interventional Cohort Study

Jay Nilesh Shah, Lily Jain, Mahan Choudhary, Shipra Verma Ronia, Anuj Chinche, Dr. Prerna Tiwari
article en

Abstract

Background: Smokeless tobacco (SLT) dependence is a pervasive public health burden across South Asia, driving high rates of oral potentially malignant disorders and cardiovascular morbidity. Conventional nicotine replacement and pharmacotherapeutic regimens show modest long-term abstinence rates in SLT chewers. Although classical homoeopathic literature describes several remedies for the constitutional and toxicological effects of tobacco, prospective clinical data evaluating individualized prescriptions remain sparse. Objectives: To evaluate the clinical effectiveness of individualized homoeopathic medicines in reducing physical nicotine dependence, subjective craving intensity, oral-health-related quality of life impairment, and daily chewing frequency among chronic smokeless tobacco users over a 6-month follow-up period. Methods: A prospective, single-blind, interventional clinical study was conducted on 100 adult smokeless tobacco users (aged 20–60 years; baseline FTND-ST score ≥ 4) at the outpatient department of Prayas Nasha-Mukti Evam Manochikitsa Kendra, Bhopal, India. Following detailed case-taking and repertorization using the Complete Repertory in CARA software, patients received one of eleven individualized homoeopathic remedies, with interspersed Sacchrum lactis (Rubrum) placebo phases to preserve single-blinding. Prescriptions distributed in descending order of clinical frequency were Arsenicum album (n = 16), Cinchona officinalis [China] (n = 14), Nux vomica (n = 13), Tabacum (n = 11), Ignatia amara (n = 10), Staphysagria (n = 9), Natrum carbonicum (n = 8), Caladium seguinum (n = 7), Erythroxylum coca (n = 5), Phosphorus (n = 4), and Spigelia anthelmia (n = 3). Outcomes were assessed at baseline and 6 months using the Fagerström Test for Nicotine Dependence–Smokeless Tobacco (FTND-ST), Oral Health Impact Profile (OHIP-18), Daily Tobacco Consumption Frequency (sessions/day), and a 0–10 Subjective Craving Visual Analogue Scale. Results: At the 6-month endpoint, statistically significant reductions were observed across the cohort (N = 100) in FTND-ST scores (6.01 ± 1.99 to 4.38 ± 2.68; mean reduction: 1.63 ± 2.07; Wilcoxon p < 0.001; d = 0.79, r = 0.45), OHIP-18 scores (baseline: 25.14 ± 8.77 vs. 6 months: 20.45 ± 9.99; mean reduction: 4.69 ± 4.17; t = 11.24, p < 0.001; Cohen’s d = 1.12), and subjective craving intensity (7.35 ± 1.84 to 5.89 ± 2.95; mean reduction: 1.46 ± 2.58; Wilcoxon p < 0.001; d = 0.57, r = 0.35). Daily chewing frequency declined from 15.10 ± 5.07 to 14.17 ± 7.09 sessions/day (mean difference: 0.93 ± 4.99; paired t-test p = 0.065; d = 0.19). Subgroup analysis demonstrated distinct clinical profiles: Ignatia amara (Δ = 6.00 ± 4.19, p = 0.001), China (Δ = 5.79 ± 4.58, p = 0.004), Staphysagria (Δ = 5.78 ± 4.66, p = 0.006), and Arsenicum album (Δ = 5.25 ± 3.04, p < 0.001) produced pronounced improvements in oral quality of life and dependence, whereas Tabacum (n = 11) achieved the most marked reduction in daily chewing sessions (Δ = 3.73 ± 4.38, p = 0.008, d = 0.85).

International Journal of Drug Delivery TechnologyVol. 16(89s)
Janardan Rai Nagar Rajasthan Vidyapeeth University (IN), Bharati Vidyapeeth (Deemed to be University) (IN)
Complementary and Alternative Medicine Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon